Ligand Pharmaceuticals Incorporated (LGND)
Jul 2, 2025 - LGND was delisted (reason: merged into PTHS)
113.30
+0.74 (0.66%)
Inactive · Last trade price
on Jul 2, 2025
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$2,668,941
Profits / Employee
-$1,950,324
Market Cap
2.19B
Employees Chart
Employees History
LGND News
- 1 day ago - Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™ - GlobeNewsWire
- 9 days ago - Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement - GlobeNewsWire
- 9 days ago - Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics - GlobeNewsWire
- 16 days ago - Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward - Seeking Alpha
- 4 weeks ago - Ligand Announces 2025 Investor Day in New York City - GlobeNewsWire
- 2 months ago - Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - GlobeNewsWire
- 2 months ago - Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ligand Reports First Quarter 2025 Financial Results - GlobeNewsWire